IP Library › Granted Patent US 12,144,814
Granted Patent B2
US 12,144,814 · App. 18/620,393 · Granted Nov 19, 2024

Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Inventor: Gary Millet (Salt Lake City, UT)
Assignee: AXCESS GLOBAL SCIENCES, LLC
A61K31/522A61K31/047A61K31/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,144,814
App. No.
18/620,393
Granted
Nov 19, 2024
Kind
B2
Abstract

Disclosed herein are “paraxanthine-BHB” compositions including a combination of: (1) paraxanthine; (2) a ketone body or ketone body precursor, such as beta-hydroxybutyrate (BHB) salt, BHB ester, BHB acid, acetoacetate salt, acetoacetate ester, acetoacetic acid, 1,3-butanediol, medium chain fatty acid, or ester of medium chain fatty acid; and (3) optionally a dietetically or pharmaceutically acceptable carrier. In some embodiments, the composition may include a short chain fatty acid or ester thereof in addition to or instead of the ketone body or ketone body precursor. The composition can provide enhanced cognitive flexibility, improved sustained attention, improved working memory, and neuroprotection in a mammal. In addition to such improved mental acuity characteristics, the composition can also beneficially increase resting energy expenditure (resting metabolic rate), enhancing fat loss principally through ketosis while promoting muscle formation and maintenance, as well as modulating lethargy/lightheadedness when entering a ketogenic state.

Claims (31)

1. A synergistic composition comprising:

paraxanthine; and

at least one ketone body or ketone body precursor selection from the group consisting of beta-hydroxybutyrate (BHB) salt, BHB ester, beta-hydroxybutyric acid, 1,3-butanediol, and combinations thereof,

wherein the composition is in a dosage form that provides from about 0.5 gram to about 50 grams of the ketone body or ketone body precursor and about 50 mg to about 500 mg of the paraxanthine.

2. The synergistic composition of claim 1 , wherein the composition comprises at least one of a BHB salt, BHB ester, or beta-hydroxybutyric acid.

3. The synergistic composition of claim 1 , wherein the composition comprises 1,3-butanediol.

4. The synergistic composition of claim 1 , wherein the composition further comprises at least one medium chain fatty acid or ester thereof.

5. The synergistic composition of claim 1 , wherein the composition further comprises at least one short chain fatty acid or ester thereof.

6. The synergistic composition of claim 1 , wherein the composition comprises a mixed salt comprising a plurality of cations selected from the group consisting of lithium ions, sodium ions, potassium ions, magnesium ions, calcium ions, and amino acid cations in combination with BHB anions.

7. The synergistic composition of claim 1 , wherein the composition is provided in solid, powder, or liquid form.

8. The synergistic composition of claim 1 , wherein the dosage form provides about 1 gram to about 40 grams, or about 2 grams to about 30 grams, or about 3 grams to about 25 grams, or about 4 grams to about 20 grams, of the ketone body or ketone body precursor.

9. The synergistic composition of claim 1 , wherein the dosage form provides about 75 mg to about 400 mg, or about 100 mg to about 300 mg, of the paraxanthine.

10. The synergistic composition of claim 1 , further comprising a pharmaceutically or dietetically acceptable carrier.

11. The synergistic composition of claim 1 , wherein the composition provides one or more benefits selected from homeostasis promotion, neuroprotection, brain protection, memory enhancement, enhanced focus and clarity, improved cognitive performance, improved working memory, improved neurotransmitter levels, reduced oxidative stress, enhanced inhibitory control (ability to control attention), anxiolytic effect, reduced jitters, anti-depressant effect, anti-inflammatory effect, analgesic effect, suppression of depressive symptoms, cardiovascular benefits, blood pressure modulation, heart rate modulation, modulation of lethargy/lightheadedness associated with hypoglycemia upon entering a ketogenic state, moderation of the downregulation of metabolic rate upon entering a ketogenic state, anti-aging, and reduced energy crash.

12. A synergistic composition comprising:

paraxanthine; and

and at least one ketone body precursor comprising 1,3-butanediol,

wherein the composition is in a dosage form that provides from about 0.5 gram to about 50 grams of the ketone body precursor and about 50 mg to about 500 mg of the paraxanthine.

13. The synergistic composition of claim 12 , wherein the composition further comprises at least one short chain fatty acid or ester thereof and/or at least one medium chain fatty acid or ester thereof.

14. The synergistic composition of claim 12 , wherein the composition is provided in solid, powder, or liquid form.

15. The synergistic composition of claim 12 , wherein the dosage form provides about 1 gram to about 40 grams, or about 2 grams to about 30 grams, or about 3 grams to about 25 grams, or about 4 grams to about 20 grams, of the ketone body precursor.

16. The synergistic composition of claim 12 , wherein the dosage form provides about 75 mg to about 400 mg, or about 100 mg to about 300 mg, of the paraxanthine.

17. The synergistic composition of claim 12 , further comprising a pharmaceutically or dietetically acceptable carrier.

18. The synergistic composition of claim 12 , wherein the composition provides one or more benefits selected from homeostasis promotion, neuroprotection, brain protection, memory enhancement, enhanced focus and clarity, improved cognitive performance, improved working memory, improved neurotransmitter levels, reduced oxidative stress, enhanced inhibitory control (ability to control attention), anxiolytic effect, reduced jitters, anti-depressant effect, anti-inflammatory effect, analgesic effect, suppression of depressive symptoms, cardiovascular benefits, blood pressure modulation, heart rate modulation, modulation of lethargy/lightheadedness associated with hypoglycemia upon entering a ketogenic state, moderation of the downregulation of metabolic rate upon entering a ketogenic state, anti-aging, and reduced energy crash.

19. A synergistic composition comprising:

paraxanthine; and

at least one ketone body or ketone body precursor selection from the group consisting of beta-hydroxybutyrate (BHB) salt, BHB ester, beta-hydroxybutyric acid, or 1,3-butanediol, and

a pharmaceutically or dietetically acceptable carrier,

wherein the composition is provided in solid, powder, or liquid form,

wherein the composition is in a dosage form that provides from about 0.5 gram to about 50 grams of the ketone body or ketone body precursor and about 50 mg to about 500 mg of the paraxanthine.

20. The synergistic composition of claim 19 , wherein the composition provides one or more benefits selected from homeostasis promotion, neuroprotection, brain protection, memory enhancement, enhanced focus and clarity, improved cognitive performance, improved working memory, improved neurotransmitter levels, reduced oxidative stress, enhanced inhibitory control (ability to control attention), anxiolytic effect, reduced jitters, anti-depressant effect, anti-inflammatory effect, analgesic effect, suppression of depressive symptoms, cardiovascular benefits, blood pressure modulation, heart rate modulation, modulation of lethargy/lightheadedness associated with hypoglycemia upon entering a ketogenic state, moderation of the downregulation of metabolic rate upon entering a ketogenic state, anti-aging, and reduced energy crash.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: MILLET, GARY
To: AXCESS GLOBAL SCIENCES, LLC
Reel/Frame 066938/0724 →
Continuity (2)
Continuation 18182125 · Mar 10, 2023
Related Publication 20240299398A1 · Sep 12, 2024